DCT

ANALYST NOTE: DCT (Duck Creek Technologies, Inc.) Date: 2026-06-13 Current Price: $18.99

1. Structural Readiness

State: Avoid

Technical Configuration:

• Conservative Entry: Not yet defined (awaiting confirmed breakout).
• Aggressive/Pre-Breakout Entry: Not actionable on setup alone; requires confirmation.
• Breakout Level: Not yet fired.
• Current Price: $18.99.
• Extension: Not applicable (price has not broken out).
• ATR Context: Current ATR is 0.2% (sub-threshold). This indicates extremely low volatility relative to the historical "sweet spot" (4–6%). While low volatility can precede a compression, the sub-threshold reading suggests a lack of immediate structural momentum or institutional positioning that typically drives a confirmed breakout.

Coil Classification:

2. Thesis Layer

Thesis Status: Tactical / Setup-Led Macro Thesis: None. There is no named secular thesis or macro theme attached to DCT as of this date. The investment case is strictly tactical, driven by the quality of the technical setup and the underlying business fundamentals. We are not assigning a "Deep Value Recovery" label based on a macro cycle, but rather observing the company's financial trajectory against its historical baseline. The conviction must be derived entirely from the setup quality and the business evidence provided, without inventing a broader market narrative.

3. Business Analysis

Company Overview: Duck Creek Technologies, Inc. operates as a provider of cloud-based core systems specifically designed for the Property and Casualty (P&C) insurance industry. The company serves both domestic (U.S.) and international markets.

Business Model & Offerings: The company operates on a SaaS (Software as a Service) model, deriving revenue from subscription fees. Its platform is modular, covering the entire insurance lifecycle:

• Duck Creek Policy: Facilitates policy administration, from product creation to quoting, binding, and service.
• Duck Creek Claims: Supports end-to-end claims processing, from first notice of loss to final settlement.
• Duck Creek Rating: Enables insurers to build complex rate models and generate instant quotes via advanced algorithms.
• Duck Creek Insights: An analytics platform aggregating internal and external data for reporting.
• Duck Creek Reinsurance Management: Automates reinsurance administrative and financial tasks.
• Duck Creek Industry Content: Provides pre-built business rules, product designs, and workflows for specific lines (e.g., commercial auto, workers' comp).

Financial Evidence (Source Date: 2023-01-05): While the current date is 2026, the only available point-in-time financial evidence provided in the dataset is from the Q4 2022/Early 2023 period.

• Revenue: Reported total revenue of $80.6 million for the quarter, up 10% year-over-year.
• Subscription Revenue: SaaS revenue was $43.8 million, up 23% year-over-year, indicating a strong shift toward recurring revenue streams.
• ARR: Annual Recurring Revenue (ARR) stood at $180.6 million, representing 24% growth over the prior year.
• Profitability: The company reported adjusted EBITDA of $3.2 million, marking the 16th consecutive quarter of profitability.
• Deal Activity: In the first quarter of that reporting period, the company signed nine SaaS deals across core and strategic solutions for customers of all sizes.

*Note: No financial data for 2024, 2025, or 2026 is available in the evidence base. The business description relies on the 2026 company profile cache which confirms the continued existence of these product lines.*

4. Archetype and Conviction

Archetype: Deep Value Recovery Rationale: The classification as "Deep Value Recovery" is based on the company's historical trajectory of consistent profitability (16 consecutive quarters as of early 2023) and strong ARR growth (24%), contrasted against a current price of $18.99 which may represent a valuation compression relative to its growth metrics. The archetype suggests the market may be undervaluing the company's stable, recurring revenue engine.

Conviction Stack:

• Thesis Strength: Low. The thesis is tactical and lacks a named macro driver.
• Evidence Quality: Mixed. The business description is robust (2026 profile), but the financial data is stale (2023). We lack current revenue, ARR, or margin data for 2024–2026 to confirm if the growth trajectory has continued or stalled.
• Structural Quality: Moderate. The setup is "Forming," which is a positive signal but incomplete. The sub-threshold ATR (0.2%) indicates a lack of volatility, which can be a precursor to a move but also suggests a lack of immediate conviction from the market.
• Setup Readiness: Low. The breakout has not fired. The setup is not actionable on its own.
• Rerating Potential: Unknown. Without current earnings data, we cannot assess if the market is pricing in a recovery or if the stock is simply stagnant.

Valuation Context: No current valuation multiples (P/S, P/E) are available in the evidence base. The "Deep Value" label is inferred from the archetype selection rather than a calculated discount to intrinsic value based on 2026 financials.

5. Invalidations, Strengths, and Gaps

What Would Invalidate the Case:

• Evidence of a significant decline in ARR growth or a breach of the 16-quarter profitability streak (if the streak has ended).
• A sustained period of negative free cash flow or a shift to a loss-making model.

What Would Strengthen the Case:

• A confirmed breakout above the forming coil resistance with volume expansion.
• Release of 2024–2026 earnings data showing sustained ARR growth >20% and continued profitability.
• Management guidance indicating an acceleration in deal velocity or expansion into new insurance lines.

Gaps in Evidence Base:

• Critical Missing Data: No financial results for 2024, 2025, or 2026. The last earnings transcript is from January 2023. We cannot verify if the 24% ARR growth or 10% revenue growth has continued, accelerated, or decelerated.
• Missing Guidance: No management expectations or forward-looking statements from 2026 are available to frame the "Deep Value" thesis.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: low Key evidence: 16 consecutive quarters of profitability as of 2023; 24% ARR growth in 2023; comprehensive SaaS product suite confirmed in 2026 profile. Key risks: Stale financial data (no 2024-2026 results); sub-threshold volatility (0.2% ATR) indicating lack of momentum; no named macro thesis to support a recovery. Sizing hint: Position size should be minimal or zero until a confirmed breakout or updated financials are released. Expected path: Management expectations for continued ARR growth and profitability will need to be validated by upcoming earnings releases to shift the setup from "Forming" to "Confirmed." Expected horizon: Indefinite until technical breakout or fundamental data update.